Feb 10 (Reuters) - Canada's Aurora Cannabis Inc (ACB.TO) would be open to undertake more merger and acquisition deals in the future to expand its medical cannabis business, the company's chief executive said on Friday.
The upbeat comments followed the cannabis producer's surprise second-quarter core profit, helped by cost saving measures it had been taking since early 2020.
"The net cash position gives us the opportunity to do M&A," CEO Miguel Martin told Reuters in an interview.
In its earnings release late on Thursday, Aurora said it has about C$310 million ($232 million) of cash, including C$65 million of restricted cash as of Feb. 8.
"I think the type of M&A we would do would be consistent with what you saw with Bevo, predictable profitable… steady business," Martin said.